World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01052285
Date of registration: 19/01/2010
Prospective Registration: Yes
Primary sponsor: Glostrup University Hospital, Copenhagen
Public title: The Efficacy of Transversus Abdominis Plane Block After Groin Hernia Repair
Scientific title: The Efficacy of Transversus Abdominis Plane Block Versus Placebo Versus Local Infiltration in Patients Undergoing Groin Hernia Repair in Day Case Surgery.
Date of first enrolment: June 2010
Target sample size: 90
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01052285
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment  
Phase:  Phase 4
Countries of recruitment
Denmark
Contacts
Name:     Pernille L Petersen, MD
Address: 
Telephone:
Email:
Affiliation:  Glostrup University Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- 18-75 years old

- groin hernia repair

- written consent

- ASA 1-3

- BMI 18-35

Exclusion Criteria:

- unable to communicate in Danish

- relevant drug allergy

- pain medication in the last 24 hours

- pregnancy

- alcohol or/and drug abuse

- daily opioid intake

- infection at injection site



Age minimum: 18 Years
Age maximum: 75 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Hernia
Intervention(s)
Procedure: Local infiltration
Procedure: Saline
Procedure: Transversus abdominis plane block
Primary Outcome(s)
Pain scores by coughing between TAP block group and placebo group [Time Frame: 0,2,4,6,8,19 and 24 hours postoperative]
Secondary Outcome(s)
Pain scores at rest between TAP block versus placebo and TAP block versus infiltration and infiltration versus placebo [Time Frame: 0,2,4,6,8,19,24 hours postoperative]
Total opioid consumption [Time Frame: 0-24 hours postoperative]
Postoperative nausea and vomiting [Time Frame: 0,2,4,6,8,19,24 hours postoperative]
Pain scores by coughing between placebo and local infiltration and between TAP block and local infiltration. [Time Frame: 0,2,4,6,8,19 and 24 hours postoperative]
Sedation [Time Frame: 0,2,4,6,8,19,24 hours postoperative]
Secondary ID(s)
2010-018403-29
SM1-plp-10
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history